Institute of Pharmaceutics and Biopharmaceutics, Heinrich-Heine-University, Duesseldorf, Germany.
Drug Dev Ind Pharm. 2009 Aug;35(8):904-16. doi: 10.1080/03639040802698794.
The performance of carrier-based dry powder inhalation formulations strongly depends on particle interactions between the drug and the carrier. Among other factors like particle size and shape, surface properties of the interacting partners play a decisive role. This study aims at investigating the effect of carrier surface characteristics on the in vitro deposition of ordered mixtures containing salbutamol sulfate as a drug and lactose and mannitol as model carrier compounds.
The wet decantation method was used to remove the carrier fines adhered to the carrier surface and to obtain smoother carrier surfaces. In vitro deposition was investigated using the Next Generation Impactor.
In comparison to the formulations containing untreated carriers, the removal of carrier fines by wet decantation leads to a reduced in vitro deposition. This is possibly caused by an increase in the surface smoothness and an increase in the number of high energetic spots.
载体干粉吸入制剂的性能很大程度上取决于药物与载体之间的颗粒相互作用。除了颗粒大小和形状等因素外,相互作用伙伴的表面特性也起着决定性的作用。本研究旨在探讨载体表面特性对含有硫酸沙丁胺醇作为药物和乳糖及甘露醇作为模型载体化合物的有序混合物体外沉积的影响。
采用湿沉降法去除附着在载体表面的载体细粉,获得更光滑的载体表面。使用下一代撞击器研究体外沉积。
与含有未处理载体的制剂相比,通过湿沉降去除载体细粉会导致体外沉积减少。这可能是由于表面光滑度增加和高能点数量增加所致。